U.S. Markets closed

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
0.37-0.01 (-2.63%)
At close: 3:57PM EDT
Full screen
Previous Close0.38
Open0.37
Bid0.37 x 0
Ask0.37 x 0
Day's Range0.37 - 0.37
52 Week Range0.18 - 0.40
Volume14,000
Avg. Volume56,803
Market Cap31.34M
Beta0.99
PE Ratio (TTM)-16.09
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q3, 2017 By the Numbers : August 22, 2017
    Capital Cubelast month

    Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q3, 2017 By the Numbers : August 22, 2017

    Categories: Yahoo FinanceGet free summary analysis Microbix Biosystems, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Microbix Biosystems, Inc. – ProMetic Life Sciences Inc., Spectral Medical Inc, Ceapro Inc., Aeterna Zentaris Inc. and ProMIS Neurosciences Inc. (PLI-CA, EDT-CA, CZO-CA, AEZS-US and PMN-CA) that have ... Read more (Read more...)

  • Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 3, 2017
    Capital Cube2 months ago

    Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q2, 2017 By the Numbers : August 3, 2017

    Categories: Yahoo FinanceGet free summary analysis Microbix Biosystems, Inc. reports financial results for the quarter ended March 31, 2017. Highlights Summary numbers: Revenues of CAD 2.65 million, Net Earnings of CAD 0.26 million. Gross margins widened from 47.71% to 52.34% compared to the same period last year, operating (EBITDA) margins now 16.36% from 16.85%. Change in operating ... Read more (Read more...)

  • Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q4, 2016 By the Numbers : January 19, 2017
    Capital Cube8 months ago

    Microbix Biosystems, Inc. :MBX-CA: Earnings Analysis: Q4, 2016 By the Numbers : January 19, 2017

    Categories: Yahoo Finance Get free summary analysis Microbix Biosystems, Inc. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of Microbix Biosystems, Inc. – IBEX Technologies Inc. and Generex Biotechnology Corporation (IBT-CA and GNBT-US) that have also reported for this period. Highlights Summary numbers: Revenues of CAD 3.47 ... Read more (Read more...)